Coeptis Therapeutics Inc.

COEP | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.99

-$1.03 (-8.57%)

At close: Jul 2, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-11.92M	-10.88M	-21.27M	-37.57M	-13.45M	-9.16M
Depreciation & Amortization	1.22M	1.04M	1.04M	1M	447.41K	323.43K
Stock-Based Compensation	1.22M	1.1M	477.5K	n/a	1.9M	n/a
Other Working Capital	-1.07M	259.42K	437.31K	-507.19K	-1M	472.68K
Other Non-Cash Items	2.34M	2.21M	10.79M	33.25M	4.26M	3.03M
Deferred Income Tax	n/a	n/a	n/a	n/a	5.34M	n/a
Change in Working Capital	-1.46M	-125.26K	1.73M	-550.34K	-2.98M	2.66M
Operating Cash Flow	-8.6M	-6.65M	-7.24M	-3.88M	-4.49M	-3.14M
Capital Expenditures	n/a	n/a	n/a	n/a	-1.75M	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-75.75M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	-1.75M	-75.75M
Debt Repayment	771.25K	1.2M	-575K	-2.42M	-1.62M	1.83M
Common Stock Repurchased	n/a	n/a	n/a	n/a	-247.17K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	500K	200K	4.63M	-50.9K	n/a
Financial Cash Flow	13.74M	5.71M	4.92M	5.49M	8.22M	2.9M
Net Cash Flow	5.14M	-936.25K	-2.32M	1.61M	1.98M	-237.12K
Free Cash Flow	-8.6M	-6.65M	-7.24M	-3.88M	-6.24M	-3.14M
Adj. Free Cash Flow	-9.82M	-7.75M	-7.72M	-3.88M	-8.14M	-3.14M
Maintenance CapEx	n/a	n/a	n/a	n/a	-1.71M	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-44.17K	n/a
Owner Earnings	-8.6M	-6.65M	-7.24M	-3.88M	-6.2M	-3.14M